Back
Cidara Therapeutics Vs. Arbutus Biopharma Industry Stock Comparison
Buy
85
CDTX
Cidara Therapeutics
Last Price:
20.68
Seasonality Move:
10.99%
Sell
37
ABUS
Arbutus Biopharma
Last Price:
3.51
Seasonality Move:
24.22%
Buy
85
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
- The current Cidara Therapeutics [CDTX] share price is $20.40. The Score for CDTX is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- CDTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
37
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $20.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.46 | Buy |
Relative Strength Index (14 RSI): | 87.39 | Buy |
Chaikin Money Flow: | 119404 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.7 - 15.64) | Buy |
Bollinger Bands (100): | (10.76 - 13.72) | Buy |
ABUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 34.97 | Sell |
Chaikin Money Flow: | 429896 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.59 - 4.01) | Sell |
Bollinger Bands (100): | (3.58 - 4.12) | Sell |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.79 | Buy |
20-day SMA: | 14.21 | Buy |
50-day SMA: | 12.3 | Buy |
200-day SMA: | 13.05 | Buy |
8-day EMA: | 16.36 | Buy |
20-day EMA: | 14.59 | Buy |
50-day EMA: | 13.14 | Buy |
200-day EMA: | 13.37 | Buy |
ABUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.54 | Sell |
20-day SMA: | 3.74 | Sell |
50-day SMA: | 3.89 | Sell |
200-day SMA: | 3.38 | Buy |
8-day EMA: | 3.55 | Sell |
20-day EMA: | 3.69 | Sell |
50-day EMA: | 3.8 | Sell |
200-day EMA: | 3.43 | Buy |
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Cidara Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arbutus Biopharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |